InvestorsHub Logo
Followers 9
Posts 273
Boards Moderated 0
Alias Born 04/09/2014

Re: wallstreethustler post# 12232

Wednesday, 12/17/2014 10:38:48 AM

Wednesday, December 17, 2014 10:38:48 AM

Post# of 64419
Thank You for the Link

The press release doesn't mention store shelves or retail outlets, only "distributors." Pet Pain Away is only going to be sold through the MLM and while the 10Qs used to read:

In September of 2012 we began distributing Nyloxin ® through TCN International, a Network Marketing Company. TCN distributes products and software applications to approximately 400,000 independent agents in more than 30 countries, including more than 40,000 agents in the United States.



TCN (MyNyloxin) claimed closer to 3,000 distributors in a promotional video last month and may well have been exaggerating at that.

The website link for Pet Pain Away given in that press release is:

http://www.petpainaway.com/ and at the bottom of that page it reads:

Pet Pain-Away is offered exclusively by Lumaxa.com



Who is Lumaxa? It's MyNylxon rebranded. Interesting choice, it means more than a years worth of advertising is going out the window, all efforts to promote the MyNyloxin brand from a keyword or SEO perspective take a major hit as existing backlinks may redirect to the new URLs but wont add to link weighting. In some ways they're starting again from square one.

Why take that hit? I'm sure the official answer is something like "we are offering far more products than just Nyloxin and need to reflect that" and that is true. They are soon to be marketing gums and weight loss products (not produced by NPHC) and perhaps even a zeolite product which Rik may stand to profit from personally but I'll wait for quarterly filings to indicate if NPHC shareholders will share in the take.

But I believe the real reason for the rebranding effort has less to do with product portfolio and is more about stalled momentum. TCN International (the MLM division) has been known as "Text Cash Network," "True Cash Network" and several other names prior to becoming "MyNyloxin" and now "Lumaxa," each and every interation along the line focused more on affiliate signup fees than product sales. Quick hit money game players are like momentum investors, no buzz no interest. Unlike stocks which can regain momentum pyramid schemes seldom get moving twice which is why Lumaxa is just as happy to pretend to be something new, something that didn't already grind to an almost terminal halt.